Goldman Sachs’s Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 ACII.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-43,317
Closed -$37K 6841
2021
Q3
$37K Buy
+43,317
New +$46K ﹤0.01% 6098

Other funds holding ACII.WS

Goldman Sachs's ACII.WS Position: Q4 2021 in Review

Goldman Sachs sold out of Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 (ACII.WS) in Q4 2021, closing a stake of 43,317 shares — an estimated $37K sold.

Goldman Sachs first reported a position in ACII.WS in Q3 2021 and held it in 1 quarter. The position peaked at $37K in Q3 2021. 51 funds tracked by Wall St. Rank hold ACII.WS as of Q4 2021.

  • Goldman Sachs reported no remaining Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
  • Goldman Sachs sold 43,317 Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 shares in Q4 2021, an estimated $37K.
  • Goldman Sachs first reported a position in Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 in Q3 2021 and held it in 1 quarter.
  • Goldman Sachs's Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position peaked at $37K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 as of Q4 2021.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.